Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-Glucosylceramide in NASH
NCT02126306Phase 2Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Jan 2006
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of beta-glucosylceramide in Nonalcoholic steatohepatitis (NASH), insulin resistance (IR), sponsored by Hadassah Medical Organization. Started Jan 2006; status: completed.
02
Drugs
beta-glucosylceramide
03
Conditions
Nonalcoholic steatohepatitis (NASH)insulin resistance (IR)
Beyond the preview
Go deeper on NCT02126306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02126306.